0001140361-23-060235.txt : 20231229
0001140361-23-060235.hdr.sgml : 20231229
20231229170540
ACCESSION NUMBER: 0001140361-23-060235
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20231228
FILED AS OF DATE: 20231229
DATE AS OF CHANGE: 20231229
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Venkatesan Jay
CENTRAL INDEX KEY: 0001413350
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39990
FILM NUMBER: 231528458
MAIL ADDRESS:
STREET 1: C/O AYER CAPITAL MANAGEMENT, LP
STREET 2: 230 CALIFORNIA ST, SUITE 600
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94111
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Elicio Therapeutics, Inc.
CENTRAL INDEX KEY: 0001601485
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 113430072
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 451 D STREET, 5TH FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02210
BUSINESS PHONE: (857) 209-0050
MAIL ADDRESS:
STREET 1: 451 D STREET, 5TH FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02210
FORMER COMPANY:
FORMER CONFORMED NAME: Angion Biomedica Corp.
DATE OF NAME CHANGE: 20140228
4
1
form4.xml
FORM 4
X0508
4
2023-12-28
0001601485
Elicio Therapeutics, Inc.
ELTX
0001413350
Venkatesan Jay
C/O ELICIO THERAPEUTICS, INC.
451 D STREET, 5TH FLOOR, SUITE 501
BOSTON
MA
02210
true
false
Stock Option (right to buy)
8.26
2023-12-28
4
A
0
4100
0
A
2033-12-28
Common Stock
4100
4100
D
The stock option, granted in lieu of the annual equity award under the Issuer's Amended and Restated Non-Employee Director Compensation Policy, vests in full on the earlier of (A) December 28, 2024, the one-year anniversary of the grant date, or (B) immediately prior to the next annual meeting of the Issuer's stockholders, subject to the Reporting Person continuing to provide services to the Issuer through such vesting date.
/s/ Jay Venkatesan
2023-12-28